Urology Institute, University Hospitals Cleveland Health System, Cleveland, Ohio, USA.
Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Neurourol Urodyn. 2023 Aug;42(6):1421-1430. doi: 10.1002/nau.25206. Epub 2023 May 20.
Perioperative antimicrobial prophylaxis is crucial for prevention of prosthesis and patient morbidity after artificial urinary sphincter (AUS) placement. While antibiotic guidelines exist for many urologic procedures, adoption patterns for AUS surgery are unclear. We aimed to assess trends in antibiotic prophylaxis for AUS and outcomes relative to American Urological Association (AUA) Best Practice guidelines.
The Premier Healthcare Database was queried from 2000 to 2020. Encounters involving AUS insertion, revision/removal, and associated complications were identified via ICD and CPT codes. Premier charge codes were used to identify antibiotics used during the insertion encounter. AUS-related complication events were found using patient hospital identifiers. Univariable analysis between hospital/patient characteristics and use of guideline-adherent antibiotics was done via chi-squared and Kruskal-Wallis tests. A multivariable logistic mixed effects model was used to assess factors related to the odds of complication, specifically the use of guideline-adherent versus nonadherent regimens.
Of 9775 patients with primary AUS surgery, 4310 (44.1%) received guideline-adherent antibiotics. The odds of guideline-adherent regimen use increased 7.7% per year with 53.0% (830/1565) receiving guideline-adherent antibiotics by the end of the study period. Patients with guideline-adherent regimens had a decreased risk of any complication (odds ratio [OR]: 0.83, 95% confidence interval [CI]: 0.74-0.93) and surgical revision (OR: 0.85, 95% CI: 0.74-0.96) within 3 months; however, no significant difference in infection within was noted (OR: 0.89, 95% CI: 0.68-1.17) within 3 months.
Adherence to AUA antimicrobial guidelines for AUS surgery appears to have increased over the last two decades. While guideline-adherent regimens were associated with decreased risk of any complication and surgical intervention, no significant association was found with risk of infection. Surgeons appear to be increasingly following AUA recommendations for antimicrobial prophylaxis for AUS surgery, however, further level 1 evidence should be obtained to demonstrate conclusive benefit of these regimens.
围手术期抗菌预防对于预防人工尿失禁括约肌(AUS)放置后假体和患者发病率至关重要。虽然有许多泌尿科手术的抗生素指南,但 AUS 手术的采用模式尚不清楚。我们旨在评估 AUS 围手术期抗生素预防的趋势,并评估其相对于美国泌尿外科学会(AUA)最佳实践指南的结果。
从 2000 年到 2020 年,我们对 Premier Healthcare Database 进行了查询。通过 ICD 和 CPT 代码识别涉及 AUS 插入、修订/移除和相关并发症的手术。使用 Premier 收费代码来识别插入手术过程中使用的抗生素。使用患者医院标识符找到与 AUS 相关的并发症事件。通过卡方检验和 Kruskal-Wallis 检验对医院/患者特征与使用指南一致的抗生素之间的关系进行单变量分析。使用多变量逻辑混合效应模型评估与并发症发生几率相关的因素,特别是使用指南一致与不一致的方案。
在 9775 例初次 AUS 手术患者中,有 4310 例(44.1%)接受了指南一致的抗生素治疗。使用指南一致的方案的几率每年增加 7.7%,在研究结束时,有 53.0%(830/1565)接受了指南一致的抗生素治疗。使用指南一致方案的患者发生任何并发症(优势比[OR]:0.83,95%置信区间[CI]:0.74-0.93)和手术修订(OR:0.85,95%CI:0.74-0.96)的风险降低,在 3 个月内;然而,在 3 个月内,感染风险无显著差异(OR:0.89,95%CI:0.68-1.17)。
在过去的二十年中,AUA 抗菌指南用于 AUS 手术的遵循情况似乎有所增加。虽然指南一致的方案与降低任何并发症和手术干预的风险相关,但与感染风险没有显著关联。外科医生似乎越来越遵循 AUA 对 AUS 手术抗菌预防的建议,然而,应该获得更高水平的证据来证明这些方案的明确益处。